Repression of TRIM13 by chromatin assembly factor CHAF1B is critical for AML development.
Dean ST, Ishikawa C, Zhu X, Walulik S, Nixon T, Jordan JK, Henderson S, Wyder M, Salomonis N, Wunderlich M, Greis KD, Starczynowski DT, Volk AG.
Dean ST, et al. Among authors: nixon t.
Blood Adv. 2023 Sep 12;7(17):4822-4837. doi: 10.1182/bloodadvances.2022009438.
Blood Adv. 2023.
PMID: 37205848
Free PMC article.